Misplaced Pages

Total complement activity

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Total complement activity (TCA) refers to a series of tests that determine the functioning of the complement system in an individual.

#695304

38-453: A variety of tests can be used to measure TCA, but the most commonly used on is the CH50 test. Other tests include the liposome immunoassay (LIA), single tube titration method, and the plate-hemolysis method. The test is based on the capacity of an individual's serum to lyse sheep erythrocytes coated with anti-sheep antibodies (preferably rabbit IgG ). The individual's serum is diluted until

76-407: A protease that destroys IgA . Additionally, Blastocystis species have been shown to have several subtypes that generate cysteine and aspartic protease enzymes which degrade human IgA. IgA nephropathy is caused by IgA deposits in the kidneys. The pathogenesis involves the production of hypoglycosylated IgA1, which accumulates and subsequently leads to the formation of immune complexes and

114-453: A diagnostic tool for certain conditions, such as autoimmune hepatitis , if indicated by certain symptoms. Clinically, measured IgG antibody levels are generally considered to be indicative of an individual's immune status to particular pathogens. A common example of this practice are titers drawn to demonstrate serologic immunity to measles, mumps, and rubella (MMR), hepatitis B virus , and varicella (chickenpox), among others. Testing of IgG

152-603: A highly conserved N-glycosylation site at asparagine 297 in the constant region of the heavy chain. The N-glycans attached to this site are predominantly core-fucosylated biantennary structures of the complex type. In addition, small amounts of these N-glycans also bear bisecting GlcNAc and α-2,6-linked sialic acid residues. The N-glycan composition in IgG has been linked to several autoimmune, infectious and metabolic diseases. There are four IgG subclasses (IgG1, 2, 3, and 4) in humans, named in order of their abundance in serum (IgG1 being

190-423: A lower dilution needs to be reached to achieve 50% capacity. In contrast, any individual with increased complement levels or activity would have an elevated CH50 since increasing dilution would be necessary to reach the 50% lyse marking. Decreased CH50 values may be seen in cirrhosis or hepatitis as a result of impaired complement production in the liver. It can also be seen in systemic lupus erythematosus as

228-479: A minimum concentration of 50% of the sheep's red blood cells are lysed. This is recorded as the CH50. CH50 tests the classical complement pathway and thus requires functioning C1-C9 factors. If an individual has deficient or malfunctioning complement factors, then at a baseline they have decreased capacity to lyse the erythrocytes. Therefore, any dilution to their serum would further impair this functioning, meaning that

266-424: A result of increased usage of complement factors due to the pathology of the autoimmune condition. It is decreased during attacks of hereditary angioedema (but those with the disease have a normal value in between attacks). Increased CH50 values means that their complement is hyperfunctional relative to normal, and this may be seen in cancer or ulcerative colitis . One can interpret the CH50 value along with

304-476: A specific antigen before it binds to mast cell–associated IgE. Consequently, IgG antibodies block systemic anaphylaxis induced by small quantities of antigen but can mediate systemic anaphylaxis induced by larger quantities. IgG antibodies are large globular proteins made of four peptide chains; two identical γ (gamma) heavy chains of about 50 kDa and two identical light chains of about 25 kDa. The resulting tetrameric quaternary structure, therefore, has

342-424: A total molecular weight of about 150  kDa . The two heavy chains are linked to each other and to a light chain each by disulfide bonds . The resulting tetramer has two identical halves, which together form a Y-like shape. Each end of the fork contains an identical antigen binding site. The various regions and domains of a typical IgG are depicted in the figure "Anatomy of an IgG". The Fc regions of IgGs bear

380-523: Is a poor activator of the complement system , and opsonizes only weakly. IgA exists in two isotypes , IgA1 and IgA2. They are both heavily glycosylated proteins. While IgA1 predominates in serum (~80%), IgA2 percentages are higher in secretions than in serum (~35% in secretions); the ratio of IgA1 and IgA2 secreting cells varies in the different lymphoid tissues of the human body: Both IgA1 and IgA2 have been found in external secretions like colostrum , maternal milk, tears and saliva , where IgA2

418-422: Is a terminal pathway deficiency (CH50 and AH50 both are low), classical pathway deficiency (CH50 low, AH50 normal) or alternative pathway deficiency (AH50 low, CH50 normal). This medical diagnostic article is a stub . You can help Misplaced Pages by expanding it . Immunoglobulin G Immunoglobulin G ( IgG ) is a type of antibody . Representing approximately 75% of serum antibodies in humans, IgG

SECTION 10

#1732898633696

456-472: Is also possible to distinguish forms of IgA based upon their location – serum IgA vs. secretory IgA. In secretory IgA, the form found in secretions, polymers of 2–4 IgA monomers are linked by two additional chains; as such, the molecular weight of slgA is 385kD. One of these is the J chain (joining chain), which is a polypeptide of molecular mass 15kD, rich with cysteine and structurally completely different from other immunoglobulin chains. This chain

494-470: Is formed in the IgA-secreting cells. The oligomeric forms of IgA in the external (mucosal) secretions also contain a polypeptide of a much larger molecular mass (70 kD) called the secretory component that is produced by epithelial cells . This molecule originates from the poly-Ig receptor (130 kD) that is responsible for the uptake and transcellular transport of oligomeric (but not monomeric) IgA across

532-419: Is free to diffuse throughout the lumen , with dimeric IgA and SC together forming the so-called secretory IgA (sIgA) In the gut, IgA can bind to the mucus layer covering the epithelial cells. In this way, a barrier capable of neutralizing threats before they reach the epithelial cells is formed. Secretory IgA levels fluctuate diurnally, with the highest levels found in the small intestine and feces around ZT6,

570-449: Is more prominent than in the blood. Polysaccharide antigens tend to induce more IgA2 than protein antigens. Both IgA1 and IgA2 can be in membrane-bound form. ( see B-cell receptor ) The heavy chain of IgA1, in contrast to IgA2, features an extended hinge region. This is thought to allow IgA1 to adapt more effectively to varying epitope spacings on multivalent antigens, while also presenting less resistance to bacterial proteases. It

608-484: Is not indicated for diagnosis of allergy, and there is no evidence that it has any relationship to food intolerances. IgA Immunoglobulin A ( Ig A , also referred to as sIgA in its secretory form) is an antibody that plays a role in the immune function of mucous membranes . The amount of IgA produced in association with mucosal membranes is greater than all other types of antibody combined. In absolute terms, between three and five grams are secreted into

646-410: Is produced, which dampens down inflammation by helping to curtail FcR-mediated processes. The relative ability of different IgG subclasses to fix complement may explain why some anti-donor antibody responses do harm a graft after organ transplantation. In a mouse model of autoantibody mediated anemia using IgG isotype switch variants of an anti erythrocytes autoantibody, it was found that mouse IgG2a

684-466: Is relatively different. Given the opposing properties of the IgG subclasses (fixing and failing to fix complement; binding and failing to bind FcR), and the fact that the immune response to most antigens includes a mix of all four subclasses, it has been difficult to understand how IgG subclasses can work together to provide protective immunity. In 2013, the Temporal Model of human IgE and IgG function

722-671: Is termed selective IgA deficiency and can produce a clinically significant immunodeficiency . Anti-IgA antibodies, sometimes present in individuals with low or absent IgA, can result in serious anaphylactic reactions when transfused with blood products that incidentally contain IgA. However, most persons with suspected IgA anaphylactic reactions had experienced acute generalized reactions that were from causes other than anti-IgA transfusion. Neisseria species including Neisseria gonorrhoeae (which causes gonorrhea ), Streptococcus pneumoniae , and Haemophilus influenzae type B all release

760-445: Is the most common type of antibody found in blood circulation . IgG molecules are created and released by plasma B cells . Each IgG antibody has two paratopes . Antibodies are major components of humoral immunity . IgG is the main type of antibody found in blood and extracellular fluid , allowing it to control infection of body tissues . By binding many kinds of pathogens such as viruses , bacteria , and fungi , IgG protects

798-465: The genitourinary tract , gastrointestinal tract , prostate and respiratory epithelium . It is also found in small amounts in blood. The secretory component of sIgA protects the immunoglobulin from being degraded by proteolytic enzymes; thus, sIgA can survive in the harsh gastrointestinal tract environment and provide protection against microbes that multiply in body secretions. sIgA can also inhibit inflammatory effects of other immunoglobulins. IgA

SECTION 20

#1732898633696

836-428: The body from infection. It does this through several mechanisms: IgG antibodies are generated following class switching and maturation of the antibody response, thus they participate predominantly in the secondary immune response . IgG is secreted as a monomer that is small in size allowing it to easily diffuse into tissues. It is the only antibody isotype that has receptors to facilitate passage through

874-455: The classical pathway, IgA can activate complement via the alternative and lectin pathways . The high prevalence of IgA in mucosal areas is a result of a cooperation between plasma cells that produce polymeric IgA (pIgA), and mucosal epithelial cells that express polymeric immunoglobulin receptor (pIgR). Polymeric IgA (mainly the secretory dimer) is produced by plasma cells in the lamina propria adjacent to mucosal surfaces. It binds to

912-514: The component of IgA can associate with the mucus layer that sits atop epithelial cells. Since sIgA is a poor opsonin and activator of complement, simply binding a pathogen isn't necessarily enough to contain it—specific epitopes may have to be bound to sterically hinder access to the epithelium. Clearance of IgA is mediated at least in part by asialoglycoprotein receptors , which recognizes galactose -terminating IgA N- glycans . Decreased or absent IgA due to an inherited inability to produce IgA

950-614: The epithelial cells and into secretions such as tears, saliva, sweat and gut fluid. In the blood, IgA interacts with an Fc receptor called FcαRI (or CD89 ), which is expressed on immune effector cells, to initiate inflammatory reactions. Ligation of FcαRI by IgA containing immune complexes causes antibody-dependent cell-mediated cytotoxicity (ADCC), degranulation of eosinophils and basophils , phagocytosis by monocytes , macrophages , and neutrophils , and triggering of respiratory burst activity by polymorphonuclear leukocytes . Unlike IgM and IgG , which activate complement through

988-435: The first six months of life, the newborn has the same antibodies as the mother and the child can defend itself against all the pathogens that the mother encountered in her life (even if only through vaccination) until these antibodies are degraded. This repertoire of immunoglobulins is crucial for the newborns who are very sensitive to infections, especially within the respiratory and digestive systems. IgG are also involved in

1026-459: The human placenta , thereby providing protection to the fetus in utero . Along with IgA secreted in the breast milk , residual IgG absorbed through the placenta provides the neonate with humoral immunity before its own immune system develops. Colostrum contains a high percentage of IgG, especially bovine colostrum. In individuals with prior immunity to a pathogen, IgG appears about 24–48 hours after antigenic stimulation. Therefore, in

1064-428: The individual's complement factor values to help determine the etiology. For example, if and individual has normal C3/C4 values but a decreased CH50, that can indicate a terminal complement pathway deficiency while if one has low C3 and CH50 values that can indicate an autoimmune condition such as systemic lupus erythematosus . Alternative pathway hemolytic assay ("AH50") can be used in conjunction to indicate if there

1102-539: The intestinal lumen each day. This represents up to 15% of total immunoglobulins produced throughout the body. IgA has two subclasses ( IgA1 and IgA2 ) and can be produced as a monomeric as well as a dimeric form. The IgA dimeric form is the most prevalent and, when it has bound the Secretory component, is also called secretory IgA (sIgA). sIgA is the main immunoglobulin found in mucous secretions , including tears , saliva , sweat , colostrum and secretions from

1140-619: The middle of the light period. The regulation of IgA secretion is related to the microbiota, and IgA is known to control specific members of oscillating microbes through direct interactions. However, the underlying cause of the rhythmic secretion of IgA is not completely understood and may differ from one region of the body to another. Production of sIgA against specific antigens depends on sampling of M cells and underlying dendritic cells , T cell activation, and B cell class switching in GALT, mesenteric lymph nodes , and isolated lymphoid follicles in

1178-408: The most abundant). Note: IgG affinity to Fc receptors on phagocytic cells is specific to individual species from which the antibody comes as well as the class. The structure of the hinge regions (region 6 in the diagram) contributes to the unique biological properties of each of the four IgG classes. Even though there is about 95% similarity between their Fc regions, the structure of the hinge regions

Total complement activity - Misplaced Pages Continue

1216-423: The pIgR on the basolateral surface of epithelial cells, and is taken up into the cell via endocytosis . The receptor-IgA complex passes through the cellular compartments before being secreted on the luminal surface of the epithelial cells, still attached to the receptor. Proteolysis of the receptor occurs, and the dimeric IgA molecule, along with a portion of the receptor known as the secretory component (SC),

1254-542: The production of IgA-specific IgG, further leading to tissue inflammation. Celiac disease involves IgA pathology due to the presence of IgA antiendomysial antibodies. Additional testing has been conducted using IgA trans-glutaminase autoantibodies which has been identified as a specific and sensitive for the detection of celiac disease. Henoch–Schönlein purpura (HSP) is a systemic vasculitis caused by deposits of IgA and complement component 3 (C3) in small blood vessels. HSP occurs usually in small children and involves

1292-550: The regulation of allergic reactions. According to Finkelman, there are two pathways of systemic anaphylaxis : antigens can cause systemic anaphylaxis in mice through classic pathway by cross-linking IgE bound to the mast cell receptor FcεRI, stimulating the release of both histamine and platelet activating factor (PAF). In the alternative pathway antigens form complexes with IgG, which then cross-link macrophage receptor FcγRIII and stimulates only PAF release. IgG antibodies can prevent IgE mediated anaphylaxis by intercepting

1330-477: The skin and connective tissues, scrotum, joints, gastrointestinal tract and kidneys. It usually follows an upper respiratory infection and resolves within a couple weeks as the liver clears out the IgA aggregates. Linear IgA bullous dermatosis and IgA pemphigus are two examples of IgA-mediated immunobullous diseases. IgA-mediated immunobullous diseases can often be difficult to treat even with usually effective medications such as rituximab. Vancomycin can induce

1368-430: The small intestine. sIgA primarily acts by blockading epithelial receptors (e.g. by binding their ligands on pathogens), by sterically hindering attachment to epithelial cells, and by immune exclusion. Immune exclusion is a process of agglutinating polyvalent antigens or pathogens by crosslinking them with antibody, trapping them in the mucus layer, and/or clearing them peristaltically . The oligosaccharide chains of

1406-527: Was proposed. This model suggests that IgG3 (and IgE) appear early in a response. The IgG3, though of relatively low affinity, allows IgG-mediated defences to join IgM-mediated defences in clearing foreign antigens. Subsequently, higher affinity IgG1 and IgG2 are produced. The relative balance of these subclasses, in any immune complexes that form, helps determine the strength of the inflammatory processes that follow. Finally, if antigen persists, high affinity IgG4

1444-661: Was superior to IgG1 in activating complement. Moreover, it was found that the IgG2a isotype was able to interact very efficiently with FcgammaR. As a result, 20 times higher doses of IgG1, in relationship to IgG2a autoantibodies, were required to induce autoantibody mediated pathology. Since mouse IgG1 and human IgG1 are not entirely similar in function, and the inference of human antibody function from mouse studies must be done with great care. However, both human and mouse antibodies have different abilities to fix complement and to bind to Fc receptors . The measurement of immunoglobulin G can be

#695304